Emily Li

1PUBLICATIONS
4CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 10, 2020
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer.

Preeti Narayan, Tatiana M Prowell, Jennifer J Gao

Pageof 1

Frequent Collaborators

1 joint publications

Tatiana M Prowell

1 joint publications

Jennifer J Gao

1 joint publications

Laura L Fernandes

1 joint publications

Kirsten B Goldberg